Displaying 1121 - 1140 of 5993
  • Print
Contract Number Brand Code Brand Name Active Ingredient Trade Name Package Size Formulary Category Pkg Price Unit Price Unit Description Max. Reimbursable Quantity / Month Package Description Manufacturer Code Manufacturer Name Agent Code Agent Name Benefit Therapeutic Code Therapeutic Desc Drug Contract Start Date Drug Contract End Date Status Description Default Route Max Repeats Therapeutic Head Amend Date
42 1471G CLONOTRIL 0.5MG TAB (REM) CLONAZEPA CLONAZEPAM CLONOTRIL 30'S A 3.26 0.11 TAB 240 BLIS REM REMEDICA LTD SBI MASSY DISTRIBUTION (BDOS) LTD B 281208 BENZODIAZEPINES (ANTICONVULSANTS) 2026-04-01 ORAL 6 BENZODIAZEPINES (ANTICONVULSANTS)
40 1471K APO-CLONAZEPAM 0.5MG TAB (APO/COL) CLONAZEPAM APO-CLONAZEPAM 500'S A 20.39 0.04 TABLET 240 TAB APO APOTEX INC. COL COLLINS LTD B 281208 BENZODIAZEPINES (ANTICONVULSANTS) 2022-04-01 2024-03-31 Oral 6 CENTRAL NERVOUS SYSTEM DRUGS
41 1471P APO-CLONAZEPAM 0.5MG TAB (APO) CLONAZEPAM APO-CLONAZEPAM 500'S A 17.48 0.035 TAB 240 BOTT APO APOTEX INC. ATB ANSA TRADING BARBADOS LTD B 281208 BENZODIAZEPINES (ANTICONVULSANTS) 2024-04-01 2026-03-31 ORAL 6 BENZODIAZEPINES (ANTICONVULSANTS)
40 14723 PMS-CLONAZEPAM 2MG TAB (PMS/COL) CLONAZEPAM PMS-CLONAZEPAM 100'S A 5.44 0.05 TABLET 300 TAB PMS PHARMASCIENCE COL COLLINS LTD B 281208 BENZODIAZEPINES (ANTICONVULSANTS) 2022-04-01 2024-03-31 Oral 6 CENTRAL NERVOUS SYSTEM DRUGS
42 14723 PMS-CLONAZEPAM 2MG TAB (PMS) CLONAZEPAM PMS-CLONAZEPAM 100'S A 7.75 0.08 TAB 300 BOTT PMS PHARMASCIENCE COL AVENTA BARBADOS B 281208 BENZODIAZEPINES (ANTICONVULSANTS) 2026-04-01 ORAL 6 BENZODIAZEPINES (ANTICONVULSANTS)
40 14726 APO-CLONAZEPAM 2MG TAB (APO/COL) CLONAZEPAM APO-CLONAZEPAM 100'S A 6.12 0.06 TABLET 300 TAB APO APOTEX INC. COL COLLINS LTD B 281208 BENZODIAZEPINES (ANTICONVULSANTS) 2022-04-01 2024-03-31 Oral 6 CENTRAL NERVOUS SYSTEM DRUGS
40 1472B CLONOTRIL 2MG TAB (REM/SBI) CLONAZEPAM CLONAZEPAM CLONOTRIL 3X10 C 4.24 0.14 TABLET 0 TAB REM REMEDICA LTD SBI MASSY DISTRIBUTION (BDOS) LTD B 281208 BENZODIAZEPINES (ANTICONVULSANTS) 2022-04-01 2024-03-31 Oral 0 CENTRAL NERVOUS SYSTEM DRUGS
41 1472B CLONOTRIL 2MG TAB (REM) CLONAZEPAM (C) CLONAZEPAM CLONOTRIL 3X10 C 4.24 0.1414 TAB 300 BOX REM REMEDICA LTD SBI MASSY DISTRIBUTION (BDOS) LTD B 281208 BENZODIAZEPINES (ANTICONVULSANTS) 2024-04-01 2026-03-31 ORAL 6 BENZODIAZEPINES (ANTICONVULSANTS)
42 1472B CLONOTRIL 2MG TAB (REM) CLONAZEPAM CLONAZEPAM CLONOTRIL 3X10 A 4.08 0.14 TAB 300 BLIS REM REMEDICA LTD SBI MASSY DISTRIBUTION (BDOS) LTD B 281208 BENZODIAZEPINES (ANTICONVULSANTS) 2026-04-01 ORAL 6 BENZODIAZEPINES (ANTICONVULSANTS)
41 1472R APO-CLONAZEPAM 2MG TAB (APO) CLONAZEPAM APO-CLONAZEPAM 100'S A 5.55 0.0555 TAB 300 BOTT APO APOTEX INC. ATB ANSA TRADING BARBADOS LTD B 281208 BENZODIAZEPINES (ANTICONVULSANTS) 2024-04-01 2026-03-31 ORAL 6 BENZODIAZEPINES (ANTICONVULSANTS)
40 14912 MAGNESIUM SULPHATE 50% INJ (MTP/COL) MAGNESIUM SULPHATE MAGNESIUM SULPHATE 10X2ML B 10.33 1.03 INJECTION 0 AMP MTP MARTINDALE PHARMACEUTICALS COL COLLINS LTD 281292 ANTICONVULSANTS MISCELLANEOUS 2022-04-01 2024-03-31 IV 0 CENTRAL NERVOUS SYSTEM DRUGS
41 14912 MAGNESIUM SULPHATE 50% INJ (MTP) (B) MAGNESIUM SULPHATE MAGNESIUM SULPHATE 10X2ML B 15.2 1.5195 AMP 0 BOX MTP MARTINDALE PHARMACEUTICALS COL COLLINS LTD 281292 ANTICONVULSANTS MISCELLANEOUS 2024-04-01 2026-03-31 IV 0 ANTICONVULSANTS MISCELLANEOUS
42 1491AF MAGNESIUM SULPHATE 50% INJ (JLP) MAGNESIUM SULPHATE MAGNESIUM SULPHATE 50X2ML B 40.77 0.82 AMPG 0 AMP JLP JOHN LEE PHARMACEUTICALS AHI ARMSTRONG HEALTHCARE INC 281292 ANTICONVULSANTS MISCELLANEOUS 2026-04-01 IV/IM 0 ANTICONVULSANTS MISCELLANEOUS
42 1491AH MAGNESIUM SULPHATE 50% INJ (FSB) MAGNESIUM SULPHATE MAGNESIUM SULPHATE 10X2ML B 6.14 0.61 VIAL 0 FSB FLAGSHIP BIOTECH STO BRYDEN STOKES LTD 281292 ANTICONVULSANTS MISCELLANEOUS 2026-04-01 Add to Contract as Cat B IV/IM 0 ANTICONVULSANTS MISCELLANEOUS 2026-03-05
40 1491R MAGNESIUM SULPHATE 50% INJ (MON/PHA) MAGNESIUM SULPHATE MAGNESIUM SULPHATE 10X2ML B 7.50 0.75 INJECTION 0 AMP MON MONTAGE PHARMACEUTICALS PHA PHARMACY SALES CARIBBEAN 281292 ANTICONVULSANTS MISCELLANEOUS 2022-04-01 2024-03-31 IV 0 CENTRAL NERVOUS SYSTEM DRUGS
42 1491R MAGNESIUM SULPHATE 50% INJ (MON) MAGNESIUM SULPHATE MAGNESIUM SULPHATE 10X2ML B 8.26 0.83 AMPG 0 BOX MON MONTAGE PHARMACEUTICALS PHA PHARMACY SALES CARIBBEAN 281292 ANTICONVULSANTS MISCELLANEOUS 2026-04-01 IV 0 ANTICONVULSANTS MISCELLANEOUS
41 1491T MAGNESIUM SULPHATE 50% INJ (KWA) (B) MAGNESIUM SULPHATE MAGNESIUM SULPHATE 10X2ML B 11.09 1.1091 AMP 0 BOX KWA KWALITY PHARMACEUTICALS ATB ANSA TRADING BARBADOS LTD 281292 ANTICONVULSANTS MISCELLANEOUS 2024-04-01 2026-03-31 IV 0 ANTICONVULSANTS MISCELLANEOUS
41 1491Z LASULPHATE 50% INJ (LDP) MAGNESIUM SULPHATE (B) MAGNESIUM SULPHATE LASULPHATE 10X2ML B 18.92 1.892 AMP 0 BOX LDP LABDHI PHARMA AHI ARMSTRONG HEALTHCARE INC 281292 ANTICONVULSANTS MISCELLANEOUS 2024-04-01 2026-03-31 IV/IM 0 ANTICONVULSANTS MISCELLANEOUS
40 15011 PHENOBARBITAL 15MG TAB (TEV/COL) PHENOBARBITO PHENOBARBITONE PHENOBARBITAL 28'S A 42.54 1.52 TABLET 180 TAB TEV TEVA UK LTD. COL COLLINS LTD B 281204 BARBITURATES (ANTICONVULSANTS) 2022-04-01 2024-03-31 Oral 6 CENTRAL NERVOUS SYSTEM DRUGS
42 15013 PHENOBARB 15MG TAB (PMS) PHENOBARBI PHENOBARBITONE PHENOBARB 500'S A 40.77 0.08 TAB 180 BOTT PMS PHARMASCIENCE COL AVENTA BARBADOS B 281204 BARBITURATES (ANTICONVULSANTS) 2026-04-01 ORAL 6 BARBITURATES (ANTICONVULSANTS)